Heterozygous familial hypercholesterolemia (HeFH) is a genetic disorder a person can inherit from a parent. It can cause a person to develop dangerously high cholesterol levels. HeFH affects how a ...
Discriminating between phenotypically indistinguishable heterozygous and wild-type mice presents a difficult situation for researchers attempting to find suitable breeding pairs. The authors describe ...
Eliot Brinton, MD, opens a discussion surrounding the treatment landscape for patients with homozygous familial hypercholesterolemia (HoFH). Eliot Brinton, MD: I’m Dr Elliot Brinton. I’m the president ...
VERVE-102 is an investigational gene-editing treatment designed to permanently disable the PCSK9 gene in the liver, thereby ...
Genome Wide Association Study (GWAS) of cognitive impairment after blood or marrow transplantation (BMT) for hematologic malignancy. This is an ASCO Meeting Abstract from the 2020 ASCO Annual Meeting ...
A single infusion of a gene-editing therapy called VERVE-102, which targets PCSK9 production in the liver, shows promise for lowering LDL cholesterol in patients with heterozygous familial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results